This is also evident from the fact that ∼50% of HCC patients are TP53 positive [82] and detection of serum TP53 along with AFP increased the frequency of HCC prediction from 79.5% (AFP only) to 86.3% (AFP and p53). This evidence concerns the gene AFP and hepatocellular carcinoma.